Skip to main content
Top
Published in: Diabetologia 12/2014

01-12-2014 | Article

Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes

Authors: Christiane Winkler, Jan Krumsiek, Florian Buettner, Christof Angermüller, Eleni Z. Giannopoulou, Fabian J. Theis, Anette-Gabriele Ziegler, Ezio Bonifacio

Published in: Diabetologia | Issue 12/2014

Login to get access

Abstract

Aims/hypothesis

More than 40 regions of the human genome confer susceptibility for type 1 diabetes and could be used to establish population screening strategies. The aim of our study was to identify weighted sets of SNP combinations for type 1 diabetes prediction.

Methods

We applied multivariable logistic regression and Bayesian feature selection to the Type 1 Diabetes Genetics Consortium (T1DGC) dataset with genotyping of HLA plus 40 SNPs within other type 1 diabetes-associated gene regions in 4,574 cases and 1,207 controls. We tested the weighted models in an independent validation set (765 cases, 423 controls), and assessed their performance in 1,772 prospectively followed children.

Results

The inclusion of 40 non-HLA gene SNPs significantly improved the prediction of type 1 diabetes over that provided by HLA alone (p = 3.1 × 10−25), with a receiver operating characteristic AUC of 0.87 in the T1DGC set, and 0.84 in the validation set. Feature selection identified HLA plus nine SNPs from the PTPN22, INS, IL2RA, ERBB3, ORMDL3, BACH2, IL27, GLIS3 and RNLS genes that could achieve similar prediction accuracy as the total SNP set. Application of this ten SNP model to prospectively followed children was able to improve risk stratification over that achieved by HLA genotype alone.

Conclusions

We provided a weighted risk model with selected SNPs that could be considered for recruitment of infants into studies of early type 1 diabetes natural history or appropriately safe prevention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef
4.
go back to reference Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703–707PubMedCentralPubMedCrossRef Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703–707PubMedCentralPubMedCrossRef
5.
go back to reference Todd JA, Walker NM, Cooper JD et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864PubMedCentralPubMedCrossRef Todd JA, Walker NM, Cooper JD et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864PubMedCentralPubMedCrossRef
6.
go back to reference Winkler C, Krumsiek J, Lempainen J et al (2012) A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immunol 13:549–555CrossRef Winkler C, Krumsiek J, Lempainen J et al (2012) A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immunol 13:549–555CrossRef
8.
go back to reference Buettner F, Miah AB, Gulliford SL et al (2012) Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother Oncol 103:82–87PubMedCrossRef Buettner F, Miah AB, Gulliford SL et al (2012) Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother Oncol 103:82–87PubMedCrossRef
9.
go back to reference Lunn DJ, Whittaker JC, Best N (2006) A Bayesian toolkit for genetic association studies. Genet Epidemiol 30:231–247PubMedCrossRef Lunn DJ, Whittaker JC, Best N (2006) A Bayesian toolkit for genetic association studies. Genet Epidemiol 30:231–247PubMedCrossRef
10.
go back to reference Lee KE, Sha N, Dougherty ER, Vannucci M, Mallick BK (2003) Gene selection: a Bayesian variable selection approach. Bioinformatics 19:90–97PubMedCrossRef Lee KE, Sha N, Dougherty ER, Vannucci M, Mallick BK (2003) Gene selection: a Bayesian variable selection approach. Bioinformatics 19:90–97PubMedCrossRef
11.
go back to reference Rich SS, Concannon P, Erlich H et al (2006) The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 1079:1–8PubMedCrossRef Rich SS, Concannon P, Erlich H et al (2006) The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 1079:1–8PubMedCrossRef
12.
go back to reference Walter M, Albert E, Conrad M et al (2003) IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46:712–720PubMedCrossRef Walter M, Albert E, Conrad M et al (2003) IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46:712–720PubMedCrossRef
13.
go back to reference Thümer L, Adler K, Bonifacio E et al (2010) German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results. Rev Diabet Stud 7:202–208PubMedCentralPubMed Thümer L, Adler K, Bonifacio E et al (2010) German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results. Rev Diabet Stud 7:202–208PubMedCentralPubMed
14.
go back to reference Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMedCrossRef Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMedCrossRef
15.
go back to reference Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG (2011) Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 34:1301–1305PubMedCentralPubMedCrossRef Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG (2011) Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 34:1301–1305PubMedCentralPubMedCrossRef
16.
go back to reference Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 57:1084–1092PubMedCentralPubMedCrossRef Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 57:1084–1092PubMedCentralPubMedCrossRef
17.
go back to reference Guyon I, Elisseeff A (2003) An introduction to variable and feature selection. J Mach Learn Res 3:1157–1182 Guyon I, Elisseeff A (2003) An introduction to variable and feature selection. J Mach Learn Res 3:1157–1182
19.
go back to reference Schölkopf B, Burges CJ, Smola AJ (eds) (1999) Advances in kernel methods: support vector learning. The MIT press, Cambridge Schölkopf B, Burges CJ, Smola AJ (eds) (1999) Advances in kernel methods: support vector learning. The MIT press, Cambridge
20.
go back to reference Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27:861–874CrossRef Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27:861–874CrossRef
21.
go back to reference Hastie T, Tibshirani R, Friedman J, Hastie T, Friedman J, Tibshirani R (2009) The elements of statistical learning, vol. 2, no. 1. Springer, New YorkCrossRef Hastie T, Tibshirani R, Friedman J, Hastie T, Friedman J, Tibshirani R (2009) The elements of statistical learning, vol. 2, no. 1. Springer, New YorkCrossRef
22.
go back to reference Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172, discussion 207-212PubMedCrossRef Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172, discussion 207-212PubMedCrossRef
23.
go back to reference Park T, Casella G (2008) The Bayesian Lasso. J Am Stat Assoc 103(482):681–688CrossRef Park T, Casella G (2008) The Bayesian Lasso. J Am Stat Assoc 103(482):681–688CrossRef
24.
go back to reference Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler AG (2004) IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 27:2695–2700PubMedCrossRef Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler AG (2004) IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 27:2695–2700PubMedCrossRef
25.
go back to reference Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264–266PubMedCrossRef Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264–266PubMedCrossRef
26.
go back to reference Näntö-Salonen K, Kupila A, Simell S et al (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372:1746–1755PubMedCrossRef Näntö-Salonen K, Kupila A, Simell S et al (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372:1746–1755PubMedCrossRef
27.
go back to reference TRIGR study group (2007) Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 8:117–137CrossRef TRIGR study group (2007) Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 8:117–137CrossRef
28.
go back to reference Rewers M, Bugawan TL, Norris JM et al (1996) Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39:807–812PubMedCrossRef Rewers M, Bugawan TL, Norris JM et al (1996) Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39:807–812PubMedCrossRef
29.
go back to reference Barker JM, Triolo TM, Aly TA et al (2008) Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes 57:3152–3155PubMedCentralPubMedCrossRef Barker JM, Triolo TM, Aly TA et al (2008) Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes 57:3152–3155PubMedCentralPubMedCrossRef
30.
go back to reference Nguyen C, Varney MD, Harrison LC, Morahan G (2013) Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62:2135–2140PubMedCentralPubMedCrossRef Nguyen C, Varney MD, Harrison LC, Morahan G (2013) Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62:2135–2140PubMedCentralPubMedCrossRef
Metadata
Title
Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes
Authors
Christiane Winkler
Jan Krumsiek
Florian Buettner
Christof Angermüller
Eleni Z. Giannopoulou
Fabian J. Theis
Anette-Gabriele Ziegler
Ezio Bonifacio
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 12/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3362-1

Other articles of this Issue 12/2014

Diabetologia 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.